Skip to main content
Log in

Correlation of aromatase activity with histological differentiation of breast cancer — A morphometric analysis

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Differentiation is a term that indicates the degree to which a tumor resembles histologically the tissue or cell of origin. A system to quantitate the proportion of breast cancer cells participating in glandular differentiation or remaining within ducts was employed. The degree of tumor differentiation of 58 primary breast cancers was correlated with estrogen (ER) and progesterone receptors (PR) and tumor aromatase activity. There was a significant association between tumor differentiation (≥2% cancer cells exhibiting glandular differentiation) and the presence of ER or PR in tumors. Conversely, there was no correlation between tumor differentiation and measurable tumor aromatase activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Grodin JM, Siiteri PK, MacDonald PC: Source of estrogen productíon in postmenopausal women. J Clin Endocrinol Metab 36: 207–214, 1973

    PubMed  Google Scholar 

  2. Poortman J, Thijssen JHH, Schwarz F: Androgen production and conversion to estrogen in normal postmenopausal women and in selected breast cancer patients. J Clin Endocrinol Metab 37: 101–109, 1973

    PubMed  Google Scholar 

  3. Siiteri PK, Williams JE, Takaki NK: Steroid abnormalities in endometrial and breast carcinoma: A unifying hypothesis. J Steroid Biochem 7: 897–903, 1976

    PubMed  Google Scholar 

  4. Longcope C: Methods and results of aromatization studies in vivo. Cancer Res 1982; (Suppl) 42: 3307s-3311s

    Google Scholar 

  5. Abul-Hajj YJ, Iverson R, Kiang DT: Aromatization of androgens by human breast cancer. Steroids 33: 205–221, 1979

    PubMed  Google Scholar 

  6. Li K, Chandra DP, Foo T, Adams JB, McDonald D: Steroid metabolism by human mammary carcinoma. Steroids 28: 561–574, 1976

    PubMed  Google Scholar 

  7. Miller WR, Forrest APM: Oestradiol synthesis from C19 steroids by human breast cancers. Br J Cancer 33: 116–118, 1976

    PubMed  Google Scholar 

  8. Perel E, Wilkins D, Killinger DW: The conversion of androstenedione to estrone, estradiol and testosterone in breast tissue. J Steroid Biochem 13: 89–94, 1980

    PubMed  Google Scholar 

  9. Varela RM, Dao TL: Estrogen synthesis and estradiol binding by human mammary tumors. Cancer Res 38: 2429–2433, 1978

    PubMed  Google Scholar 

  10. Siiteri PK: Review of studies on estrogen biosynthesis in the human. Cancer Res (Suppl) 42: 3269s-3273s, 1982

    Google Scholar 

  11. Tilson-Mallett N, Santner SJ, Feil PD, Santen RJ: Biological significance of aromatase activity in human breast tumors. J Clin Endocrinol Metab 57: 1125–1128, 1983

    PubMed  Google Scholar 

  12. Lipton A, Santner SJ, Santen RJ, Harvey HA, Feil PD, White-Hershey D, Bartholomew MJ, Antle CE: Aromatase activity in primary and metastatic human breast cancer. Cancer 59: 779–782, 1987

    PubMed  Google Scholar 

  13. Sharkey FE, Pavlak RJ, Greiner AS: Morphometric analysis of differentiation in human breast carcinoma. Arch Pathol Lab Med 107: 406–410, 1983

    PubMed  Google Scholar 

  14. Sharkey FE: Morphometric analysis of differentiation in human breast carcinoma. Arch Pathol Lab Med 107: 411–414, 1983

    PubMed  Google Scholar 

  15. McGuire WL, De La Garza M, Chamness GC: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res 37: 637–639, 1977

    PubMed  Google Scholar 

  16. Feil PD, Klase JC, Margets MJ: Use of medroxyprogesterone acetate to measure cytosol progestin receptors in human breast cancer (Abstr). 61st Annual Meeting of The Endocrine Society, Anaheim, California 150: 1979

  17. Thompson EA, Siiteri PK: Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem 249: 5364–5372, 1974

    PubMed  Google Scholar 

  18. Weisz J, Brown BL, Ward IL: Maternal stress decreases steroid aromatase activity in brains of male and female rat fetuses. Neuroendocrinology 35: 374–379, 1982

    PubMed  Google Scholar 

  19. Chalkley HW: Method for the quantitative morphologic analysis of tissues. JNCI 4: 47–53, 1943

    Google Scholar 

  20. Wittliff JL, Hilf R, Brooks WF Jr, Savlov ED, Hall TC, Orlando RH: Specific estrogen-binding capacity of the cytoplasmic receptor in normal and neoplastic breast tissues of humans. Cancer Res 32: 1983–1992, 1971

    Google Scholar 

  21. Johansson H, Terenius L, Thoren L: The binding of estradiol-17β to human breast cancers and other tissues in vitro. Cancer Res 30: 692–698, 1970

    PubMed  Google Scholar 

  22. Terenius L, Johansson H, Rimsten A, Thoren L: Malignant and benign human mammary disease: Estrogen binding in relation to clinical data. Cancer 33: 1364–1368, 1974

    PubMed  Google Scholar 

  23. Savlov ED: Correlations between certain biochemical properties of breast cancer and response to therapy: A preliminary report. Cancer 32: 303–309, 1973

    Google Scholar 

  24. Korenman SG, Dukes BA: Specific estrogen binding by the cytoplasm of human breast carcinoma. J Clin Endocrinol 30: 639–645, 1970

    Google Scholar 

  25. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359–377, 1957

    PubMed  Google Scholar 

  26. Rich MA, Brennan MJ: The breast cancer prognostic program: A study of the metastatic process.In: Brennan MJ, McGrath CM, Rich MA (eds) Breast Cancer: New Concepts in Etiology and Control. Academic Press, New York, 1980; pp 29–51

    Google Scholar 

  27. Delides GS, Garas G, Georgouli Get al.: Intralaboratory variations in the grading of breast carcinoma. Arch Pathol Lab Med 106: 126–128, 1982

    PubMed  Google Scholar 

  28. Rosen PP, Menendez-Botet CJ, Nisselbaum JSet al.: Pathologic review of breast lesions analyzed for estrogen receptor protein. Cancer Res 35: 3187–3194, 1975

    PubMed  Google Scholar 

  29. Mohammed RH, Lakatua DJ, Haus E, Yasmineh WJ: Estrogen and progesterone receptors in human breast cancer — correlation with histologic subtype and degree of differentiation. Cancer 58: 1076–1081, 1986

    PubMed  Google Scholar 

  30. Underwood JCE: A morphometric analysis of human breast carcinoma. Br J Cancer 26: 234–237, 1972

    PubMed  Google Scholar 

  31. Faull TW, Feil PD, Sharkey FE: Correlation of estrogen receptor levels with histological differentiation of breast cancer — a morphometric analysis. Abstract, 5th Annual San Antonio Breast Cancer Symposium, Nov. 1982

  32. Barry JD, Koch TJ, Cohen C, Brigati DJ, Sharkey FE: Correlation of immunohistochemical markers with patient prognosis in breast carcinoma. A quantitative study. Am J Clin Path 82: 582–585, 1984

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lipton, A., Santen, R.J., Santner, S.J. et al. Correlation of aromatase activity with histological differentiation of breast cancer — A morphometric analysis. Breast Cancer Res Tr 12, 31–35 (1988). https://doi.org/10.1007/BF01805737

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01805737

Key words

Navigation